Page 14 of 29

EN4.25 | Vasomotor Rhinitis — SDL Guide (Part 2)

Diagnosis and Differential Diagnosis

The diagnosis of vasomotor rhinitis rests on three pillars: a clinical history showing the characteristic perennial, trigger-driven, non-allergic symptom pattern; a negative allergy workup (SPT and/or serum-specific IgE); and exclusion of other causes of chronic rhinitis. This is a diagnosis of exclusion — there is no positive test that confirms vasomotor rhinitis. This means the clinical history is everything: the quality of the triggers (physical and chemical rather than specific allergens), the absence of itch and sneezing, and the perennial daily pattern collectively make the diagnosis. An important clinical discipline is to take a complete drug history in every patient with chronic rhinitis, because drug-induced rhinitis — from antihypertensives, beta-blockers, aspirin, and oral contraceptives — mimics vasomotor rhinitis exactly and is entirely reversible on stopping the offending drug. Missing a drug cause and labelling the patient as vasomotor rhinitis condemns them to chronic unnecessary treatment.

The differential diagnosis of vasomotor rhinitis includes:
- Allergic rhinitis: sneezing + itch + eye symptoms + positive SPT + seasonal variation; see allergic rhinitis SDL.
- NARES (non-allergic rhinitis with eosinophilia syndrome): negative SPT but nasal smear shows eosinophilia (>25%); responds well to INCS; no clear trigger pattern.
- Rhinitis medicamentosa: prolonged topical decongestant use (oxymetazoline >5–7 days); rebound congestion; history of decongestant use is the clue.
- Atrophic rhinitis: in elderly or post-surgical patients; crusting, fetid odour, paradoxical wide nasal passage (mucosal and turbinate atrophy); entirely different pathology.
- Hormonal rhinitis: pregnancy, hypothyroidism, oral contraceptive use — nasal congestion is prominent; diagnosis by context (pregnancy test, TSH).
- Drug-induced rhinitis: antihypertensives (methyldopa, reserpine, ACE inhibitors), beta-blockers, aspirin/NSAIDs — careful drug history is essential.
- Occupational rhinitis: triggered specifically by workplace allergens or irritants (flour dust, wood dust, latex, chemical fumes); relationship to work schedule (better on weekends/holidays) is the clue.

Principles of Management

The management of vasomotor rhinitis is less straightforward than allergic rhinitis because there is no single disease-modifying treatment and no allergen to avoid. Management is targeted at reducing the triggers that provoke the autonomic response, suppressing the exaggerated mucosal inflammation pharmacologically, and in refractory cases, reducing the nasal secretomotor nerve activity or the turbinate bulk surgically. The goal is symptom control, not cure — patients should be counselled that vasomotor rhinitis is a chronic, relapsing condition that requires long-term management.

Trigger avoidance:
Identifying and avoiding known triggers where practical reduces symptom frequency and severity. Strategies include: using a car air filter to reduce pollen and dust in the vehicle, avoiding perfumed products (unscented alternatives), keeping indoor humidity moderate (50–60%), and pre-medicating before unavoidable exposures (e.g., intranasal ipratropium before a meal for gustatory rhinitis).

Pharmacotherapy:

Intranasal corticosteroids (INCS) — mometasone, fluticasone, budesonide — are the most effective pharmacological treatment for vasomotor rhinitis, particularly the obstruction-dominant subtype. INCS reduce mucosal oedema, turbinate hypertrophy, and non-specific hyper-reactivity. They are less effective for the rhinorrhoea-dominant subtype than for obstruction. Require 4–6 weeks of regular use for full benefit.

Intranasal ipratropium bromide (an anticholinergic) — the treatment of choice for rhinorrhoea-dominant vasomotor rhinitis. Ipratropium blocks muscarinic receptors on nasal glands, reducing glandular secretion. Available as a nasal spray; highly effective for anterior rhinorrhoea and post-nasal drip; does not address nasal obstruction. Also first-line for gustatory rhinitis (used before meals). Side effect: nasal dryness and crusting.

Antihistamines: generally not effective for vasomotor rhinitis (there is no histamine release driving symptoms). The first-generation antihistamines (chlorpheniramine) have some anticholinergic action that may give modest benefit for rhinorrhoea — but this is an anticholinergic effect, not an antihistamine effect. Second-generation antihistamines have no anticholinergic activity and are not useful.

Nasal saline irrigation: reduces mucosal irritation, clears secretions, and improves mucociliary clearance; safe adjunct.

Surgical options (for refractory disease):
- Inferior turbinoplasty or turbinate reduction (submucosal diathermy, radiofrequency ablation, partial inferior turbinectomy): reduces the bulk of the hypertrophied inferior turbinate, improving nasal airway patency; does not cure the underlying autonomic dysregulation but improves airflow.
- Vidian neurectomy: surgical division of the vidian nerve in the pterygopalatine fossa, interrupting the parasympathetic secretomotor fibres to the nose. Reduces rhinorrhoea dramatically. Rarely performed because of technical complexity and risk of complications (dry eye from lacrimal gland denervation — the greater petrosal nerve, a parasympathetic branch to the lacrimal gland, also runs with the vidian nerve). Reserved for refractory, predominantly rhinorrhoea-dominant vasomotor rhinitis in specialist centres.

Self-Assessment

Test your clinical reasoning on this scenario before attempting the quiz. Apply the full diagnostic and management framework from this module — history pattern, subtype classification, and drug-to-symptom matching:

A 42-year-old female software engineer presents with a 4-year history of bilateral nasal obstruction and profuse watery post-nasal drip that causes throat clearing and cough. She finds symptoms worst in winter and after entering air-conditioned offices, but they are present year-round. No sneezing, no ocular symptoms, no seasonal pattern. Skin prick test negative. Nasal smear shows predominantly neutrophils, no eosinophilia.

What is the diagnosis? How would you classify the subtype? What is the FIRST pharmacological agent you would prescribe and why? If she also developed profuse rhinorrhoea after spicy meals, what specific subtype treatment would you add? What surgical option is available if all pharmacotherapy fails?